© Rosalind Scientific LLC 2018-2022
© Rosalind Scientific LLC, 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >3,500 drug hunters worldwide, unsubscribe anytime.
<< Back to January
covalent inh. of remote ALK kinase cysteine
thought-provoking proposed MoA
from ceritinib and linker opt.
J. Med. Chem., Jan. 20, 2021
Sichuan University / Tsinghua University, CN
The academic covalent ALKi inhibitor, Con B-1, is thought-provoking initial proof-of-concept that remote kinase cysteines might be targetable from an active-site inhibitor. The authors show that a derivative of…
Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.